However, it should be pointed out that these studies analyzed different study cohorts consisting of normal individuals from the general population (Radvanszky et al., 2013) or DM2-negative probands showing DM2-like symptoms (Mahyera et al., 2018 and our study). This evidence concerns the gene CNBP and myotonic dystrophy type 2.